176 related articles for article (PubMed ID: 26852855)
1. Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation.
Rui TQ; Zhang L; Qiao HZ; Huang P; Qian S; Li JS; Chen ZP; Fu TM; Di LQ; Cai B
J Pharm Sci; 2016 Jan; 105(1):242-9. PubMed ID: 26852855
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion.
Wang W; Kang Q; Liu N; Zhang Q; Zhang Y; Li H; Zhao B; Chen Y; Lan Y; Ma Q; Wu Q
Fitoterapia; 2015 Apr; 102():189-97. PubMed ID: 25446043
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model.
Wang S; Ouyang B; Aa J; Geng J; Fei F; Wang P; Wang J; Peng Y; Geng T; Li Y; Huang W; Wang Z; Xiao W; Wang G
J Pharm Biomed Anal; 2016 Jul; 126():109-16. PubMed ID: 27182682
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of amide derivatives of ginkgolide A.
Hu LH; Chen ZL; Xie YY
J Asian Nat Prod Res; 2001; 3(3):219-27. PubMed ID: 11491398
[TBL] [Abstract][Full Text] [Related]
5. Development of herpetrione nanosuspensions stabilized by glycyrrhizin for enhancing bioavailability and synergistic hepatoprotective effect.
Hang L; Hu F; Shen C; Shen B; Zhu W; Yuan H
Drug Dev Ind Pharm; 2021 Oct; 47(10):1664-1673. PubMed ID: 35188016
[TBL] [Abstract][Full Text] [Related]
6. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
Wang Y; Han X; Wang J; Wang Y
Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
[TBL] [Abstract][Full Text] [Related]
8. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
9. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Qiao H; Chen L; Rui T; Wang J; Chen T; Fu T; Li J; Di L
Int J Nanomedicine; 2017; 12():1033-1046. PubMed ID: 28223797
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
12. Novel breviscapine nanocrystals modified by panax notoginseng saponins for enhancing bioavailability and synergistic anti-platelet aggregation effect.
Jin X; Luo Y; Chen Y; Ma Y; Yue P; Yang M
Colloids Surf B Biointerfaces; 2019 Mar; 175():333-342. PubMed ID: 30554011
[TBL] [Abstract][Full Text] [Related]
13. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.
Yang D; Li R; Zhang F; Qin L; Peng F; Jiang S; He H; Lu X; Zhang P
Drug Deliv Transl Res; 2020 Feb; 10(1):192-201. PubMed ID: 31482518
[TBL] [Abstract][Full Text] [Related]
14. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
Patel GV; Patel VB; Pathak A; Rajput SJ
Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
[TBL] [Abstract][Full Text] [Related]
16. Effects of food and gender on the pharmacokinetics of ginkgolides A, B, C and bilobalide in rats after oral dosing with ginkgo terpene lactones extract.
Huang P; Zhang L; Chai C; Qian XC; Li W; Li JS; Di LQ; Cai BC
J Pharm Biomed Anal; 2014 Nov; 100():138-144. PubMed ID: 25165009
[TBL] [Abstract][Full Text] [Related]
17. Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats.
Yang ZZ; Li J; Li SX; Feng W; Wang H
J Ethnopharmacol; 2011 Jun; 136(1):117-22. PubMed ID: 21527331
[TBL] [Abstract][Full Text] [Related]
18. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
[TBL] [Abstract][Full Text] [Related]
19. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
20. Ginkgolides-loaded soybean phospholipid-stabilized nanosuspension with improved storage stability and in vivo bioavailability.
Wang P; Cao X; Chu Y; Wang P
Colloids Surf B Biointerfaces; 2019 Sep; 181():910-917. PubMed ID: 31382340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
